Key Details
Price
$1.62Annual ROE
-73.64%Beta
0.40Events Calendar
Next earnings date:
Mar 28, 2025Recent quarterly earnings:
Nov 6, 2024Recent annual earnings:
Mar 29, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Jan 5, 2024Analyst ratings
Recent major analysts updates
Jan 29, 25 HC Wainwright & Co.
BuyJan 29, 25 Chardan Capital
BuyNov 7, 24 Chardan Capital
BuyOct 9, 24 Craig-Hallum
BuySep 12, 24 Oppenheimer
OutperformSep 9, 24 Chardan Capital
BuyAug 28, 24 Oppenheimer
OutperformAug 12, 24 HC Wainwright & Co.
BuyAug 12, 24 Chardan Capital
BuyJun 7, 24 Brookline Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
SAB Biotherapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for SAB Biotherapeutics?
- Does SAB Biotherapeutics pay dividends?
- What sector is SAB Biotherapeutics in?
- What industry is SAB Biotherapeutics in?
- What country is SAB Biotherapeutics based in?
- When did SAB Biotherapeutics go public?
- Is SAB Biotherapeutics in the S&P 500?
- Is SAB Biotherapeutics in the NASDAQ 100?
- Is SAB Biotherapeutics in the Dow Jones?
- When was SAB Biotherapeutics's last earnings report?
- When does SAB Biotherapeutics report earnings?
- Should I buy SAB Biotherapeutics stock now?
What is the ticker symbol for SAB Biotherapeutics?
The ticker symbol for SAB Biotherapeutics is NASDAQ:SABS
Does SAB Biotherapeutics pay dividends?
No, SAB Biotherapeutics does not pay dividends
What sector is SAB Biotherapeutics in?
SAB Biotherapeutics is in the Healthcare sector
What industry is SAB Biotherapeutics in?
SAB Biotherapeutics is in the Biotechnology industry
What country is SAB Biotherapeutics based in?
SAB Biotherapeutics is headquartered in United States
When did SAB Biotherapeutics go public?
SAB Biotherapeutics's initial public offering (IPO) was on February 9, 2021
Is SAB Biotherapeutics in the S&P 500?
No, SAB Biotherapeutics is not included in the S&P 500 index
Is SAB Biotherapeutics in the NASDAQ 100?
No, SAB Biotherapeutics is not included in the NASDAQ 100 index
Is SAB Biotherapeutics in the Dow Jones?
No, SAB Biotherapeutics is not included in the Dow Jones index
When was SAB Biotherapeutics's last earnings report?
SAB Biotherapeutics's most recent earnings report was on Nov 6, 2024
When does SAB Biotherapeutics report earnings?
The next expected earnings date for SAB Biotherapeutics is Mar 28, 2025
Should I buy SAB Biotherapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions